Risk of Immune Thrombocytopenia After Influenza Vaccine.

Lafaurie, Margaux; Lapeyre-Mestre, Maryse; Sailler, Laurent; Sommet, Agnès; Moulis, Guillaume · JAMA Intern Med · 2022

retrospective_cohort · Level III

Where this comes from

Abstract

This cohort study uses data from the French National Health Database to examine the risk of immune thrombocytopenia after receiving influenza vaccine among patients who were 65 years or older.

Medical subject headings